170 related articles for article (PubMed ID: 27784369)
21. Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells.
Vaughan JW; Shi M; Horna P; Olteanu H
Ann Diagn Pathol; 2020 Oct; 48():151585. PubMed ID: 32829067
[TBL] [Abstract][Full Text] [Related]
22. [Expression characteristics of CD200 in acute myeloid leukemia and its clinical significance].
Zhang XL; Shen AL; Guo R; Wang Y; Qiu HR; Qiao C; Yang H; Zhang JF; Li JY; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1531-4. PubMed ID: 25543469
[TBL] [Abstract][Full Text] [Related]
23. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
25. [Cellular immune function and its clinical implications in 45 patients with multiple myeloma].
Zhu M; Wan W; Wang J; Wang Y; Li H; Ke X
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1053-7. PubMed ID: 25543696
[TBL] [Abstract][Full Text] [Related]
26. [Effect of B Lymphocyte-Induced Mature Protein-1 Expression in Bone Marrow Mononuclear Cells on Prognosis of Patients with Multiple Myeloma].
Liu GS; Wang JP; Chu ZH; Yu YY; Zhou W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1449-1453. PubMed ID: 29070123
[TBL] [Abstract][Full Text] [Related]
27. [Clinical Significance of Detecting CD4
Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma Patients.
ElMenshawy N; Farag NA; Atia DM; Abousamra N; Shahin D; Fawzi E; Ghazi H; El-Kott AF; Eissa M
Cancer Invest; 2021 Oct; 39(9):777-782. PubMed ID: 34344244
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].
Wang XX; Zhang LL; Wang T; Hou JX; Wang ZT; Qin H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):777-782. PubMed ID: 37356939
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic characterization of normal and abnormal plasma cells in bone marrow of newly diagnosed multiple myeloma patients.
Awasthi NP; Mishra S; Gupta G; Kumari S; Bajpayee A; Singh P; Husain N
Indian J Pathol Microbiol; 2023; 66(2):295-300. PubMed ID: 37077071
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
Flores-Montero J; de Tute R; Paiva B; Perez JJ; Böttcher S; Wind H; Sanoja L; Puig N; Lecrevisse Q; Vidriales MB; van Dongen JJ; Orfao A
Cytometry B Clin Cytom; 2016 Jan; 90(1):61-72. PubMed ID: 26100534
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
Mateo G; Montalbán MA; Vidriales MB; Lahuerta JJ; Mateos MV; Gutiérrez N; Rosiñol L; Montejano L; Bladé J; Martínez R; de la Rubia J; Diaz-Mediavilla J; Sureda A; Ribera JM; Ojanguren JM; de Arriba F; Palomera L; Terol MJ; Orfao A; San Miguel JF; ;
J Clin Oncol; 2008 Jun; 26(16):2737-44. PubMed ID: 18443352
[TBL] [Abstract][Full Text] [Related]
33. The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients.
Ceran F; Falay M; Dağdaş S; Özet G
Turk J Haematol; 2017 Aug; 34(3):226-232. PubMed ID: 28270374
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotypic characterization and quantification of neoplastic bone marrow plasma cells by multiparametric flow cytometry and its clinical significance in Korean myeloma patients.
Cho YU; Park CJ; Park SJ; Chi HS; Jang S; Park SH; Seo EJ; Yoon DH; Lee JH; Suh C
J Korean Med Sci; 2013 Apr; 28(4):542-9. PubMed ID: 23580331
[TBL] [Abstract][Full Text] [Related]
35. [Immunophenotype characteristics in multiple myeloma cells and their significance].
Sun Y; Fang MY; Liu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):381-4. PubMed ID: 20416173
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic Value of CD27 Antigen in Patients with Multiple Myeloma].
Wang H; Liu L; Liu F; Chen LJ; Qu XY; Li JY; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1069-1073. PubMed ID: 28823270
[TBL] [Abstract][Full Text] [Related]
37. The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma.
Guo J; Su J; He Q; Li X; Zhao Y; Gu S; Fei C; Chang C
Hematology; 2016 Apr; 21(3):152-61. PubMed ID: 25860485
[TBL] [Abstract][Full Text] [Related]
38. More frequent IgD and reduced CD200 expression in Chinese patients younger than 50 years old with multiple myeloma: a multicenter analysis.
Lu J; Lu J; Chen W; Wang J; Huo Y; Hou J; Huang X
Drug Des Devel Ther; 2016; 10():3673-3679. PubMed ID: 27877018
[TBL] [Abstract][Full Text] [Related]
39. Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma.
Ma T; Shi J; Xiao Y; Bian T; Wang J; Hui L; Wang M; Liu H
Front Immunol; 2021; 12():724411. PubMed ID: 34867949
[TBL] [Abstract][Full Text] [Related]
40. [CD200/CD200R Expression Levels and Its Significance after Allogeneic Hematopoietic Stem Cell Transplantation].
Huang YH; Zhang W; Cai H; Li TJ; Li J; Han B; Zhuang JL; Zhu TN; Cai HC; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):815-20. PubMed ID: 27342516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
